Flurbiprofen benzyl nitrate (NBS-242) inhibits the growth of A-431 human epidermoid carcinoma cells and targets β-catenin

References

• American Cancer Society Cancer Facts and Figures 2010 Atlanta American Cancer Society 2010 Available from: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-026238.pdf Accessed March 26, 2013
   Google Scholar
• Tataroglu C Karabacak T Apa DD Beta-catenin and CD44 expression in keratoacanthoma and squamous cell carcinoma of the skin Tumori 2007 93 3 284 289 17679465
   PubMed Web of Science ®Google Scholar
• Doglioni C Piccinin S Demontis S Alterations of beta-catenin pathway in non-melanoma skin tumors: loss of alpha-ABC nuclear reactivity correlates with the presence of beta-catenin gene mutation Am J Pathol 2003 163 6 2277 2287 14633602
   PubMed Web of Science ®Google Scholar
• El-Bahrawy M El-Masry N Alison M Poulsom R Fallowfield M Expression of beta-catenin in basal cell carcinoma Br J Dermatol 2003 148 5 964 970 12786827
   PubMed Web of Science ®Google Scholar
• Bhatia N Spiegelman VS Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis Mol Carcinog 2005 42 4 213 221
   Web of Science ®Google Scholar
• Thun MJ Henley SJ Patrono C Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues J Natl Cancer Inst 2002 94 4 252 266 11854387
   PubMed Web of Science ®Google Scholar
• Baron JA Epidemiology of non-steroidal anti-inflammatory drugs and cancer Prog Exp Tumor Res 2003 37 1 24
   PubMed Web of Science ®Google Scholar
• Benamouzig R Deyra J Martin A Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial Gastroenterology 2003 125 2 328 336
   PubMed Web of Science ®Google Scholar
• Sandler RS Halabi S Baron JA A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer N Engl J Med 2003 348 10 883 890
   PubMed Web of Science ®Google Scholar
• Rothwell PM Price JF Fowkes FG Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials Lancet 2012 379 9826 1602 1612
   PubMed Web of Science ®Google Scholar
• Rothwell PM Wilson M Price JF Belch JF Meade TW Mehta Z Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials Lancet 2012 379 9826 1591 1601
   PubMed Web of Science ®Google Scholar
• Clouser MC Roe DJ Foote JA Harris RB Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial Pharmacoepidemiol Drug Saf 2009 18 4 276 283 19226541
   PubMed Web of Science ®Google Scholar
• Elmets CA Viner JL Pentland AP Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial J Natl Cancer Inst 2010 102 24 1835 1844 21115882
   PubMed Web of Science ®Google Scholar
• Curiel-Lewandrowski C Nijsten T Gomez ML Hollestein LM Atkins MB Stern RS Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study J Invest Dermatol 2011 131 7 1460 1468 21390049
   PubMed Web of Science ®Google Scholar
• Bjorkman DJ Current status of nonsteroidal anti-inflammatory drug (NSAID) use in the United States: risk factors and frequency of complications Am J Med 1999 107 6A 3S 8S discussion 8S–10S 10628588
   PubMedGoogle Scholar
• Fitzgerald GA Coxibs and cardiovascular disease N Engl J Med 2004 351 17 1709 1711 15470192
   PubMed Web of Science ®Google Scholar
• Scheiman JM Fendrick AM Summing the risk of NSAID therapy Lancet 2007 369 9573 1580 1581 17499583
   PubMed Web of Science ®Google Scholar
• Davies NM Røseth AG Appleyard CB NO-naproxen vs naproxen: ulcerogenic, analgesic and anti-inflammatory effects Aliment Pharmacol Ther 1997 11 1 69 79 9042976
   PubMed Web of Science ®Google Scholar
• Wallace JL Reuter B Cicala C McKnight W Grisham MB Cirino G Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat Gastroenterology 1994 107 1 173 179 8020659
   PubMed Web of Science ®Google Scholar
• Fiorucci S Santucci L Gresele P Faccino RM Del Soldato P Morelli A Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study Gastroenterology 2003 124 3 600 607
   PubMed Web of Science ®Google Scholar
• Fiorucci S Santucci L Wallace JL Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa Proc Natl Acad Sci U S A 2003 100 19 10937 10941 12960371
   PubMed Web of Science ®Google Scholar
• Kashfi K Borgo S Williams JL Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo J Pharmacol Exp Ther 2005 312 3 978 988 15528453
   PubMed Web of Science ®Google Scholar
• Rigas B Kashfi K Nitric-oxide-donating NSAIDs as agents for cancer prevention Trends Mol Med 2004 10 7 324 330 15242680
   PubMed Web of Science ®Google Scholar
• Nath N Labaze G Rigas B Kashfi K NO-donating aspirin inhibits the growth of leukemic Jurkat cells and modulates beta-catenin expression Biochem Biophys Res Commun 2005 326 1 93 99 15567157
   PubMed Web of Science ®Google Scholar
• Penning TD Talley JJ Bertenshaw SR Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib) J Med Chem 1997 40 9 1347 1365 9135032
   PubMed Web of Science ®Google Scholar
• Cong F Zhang J Pao W Zhou P Varmus H A protein knockdown strategy to study the function of beta-catenin in tumorigenesis BMC Mol Biol 2003 4 10 14516475
   PubMed Web of Science ®Google Scholar
• Maier TJ Janssen A Schmidt R Geisslinger G Grösch S Targeting the beta-catenin/APC pathway: a novel mechanism to explain the cyclooxygenase-2-independent anticarcinogenic effects of celecoxib in human colon carcinoma cells FASEB J 2005 19 10 1353 1355 15946992
   PubMed Web of Science ®Google Scholar
• Kashfi K Rigas B The mechanism of action of nitric oxide-donating aspirin Biochem Biophys Res Commun 2007 358 4 1096 1101 17512900
   PubMed Web of Science ®Google Scholar
• Dunlap T Chandrasena RE Wang Z Sinha V Wang Z Thatcher GR Quinone formation as a chemoprevention strategy for hybrid drugs: balancing cytotoxicity and cytoprotection Chem Res Toxicol 2007 20 12 1903 1912 17975886
   PubMed Web of Science ®Google Scholar
• Hulsman N Medema JP Bos C Chemical insights in the concept of hybrid drugs: the antitumor effect of nitric oxide-donating aspirin involves a quinone methide but not nitric oxide nor aspirin J Med Chem 2007 50 10 2424 2431 17441704
   PubMed Web of Science ®Google Scholar
• Hsieh T Halicka D Lu X Effects of resveratrol on the G(0)-G(1) transition and cell cycle progression of mitogenically stimulated human lymphocytes Biochem Biophys Res Commun 2002 297 5 1311 1317 12372431
   PubMed Web of Science ®Google Scholar